In reply
Publication
, Journal Article
Vredenburgh, JJ; Rich, JN; Reardon, DA; Desjardins, A; Friedman, HS
Published in: Journal of Clinical Oncology
November 10, 2008
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
ISSN
0732-183X
Publication Date
November 10, 2008
Volume
26
Issue
32
Start / End Page
5305
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vredenburgh, J. J., Rich, J. N., Reardon, D. A., Desjardins, A., & Friedman, H. S. (2008). In reply. Journal of Clinical Oncology, 26(32), 5305. https://doi.org/10.1200/JCO.2008.18.0372
Vredenburgh, J. J., J. N. Rich, D. A. Reardon, A. Desjardins, and H. S. Friedman. “In reply.” Journal of Clinical Oncology 26, no. 32 (November 10, 2008): 5305. https://doi.org/10.1200/JCO.2008.18.0372.
Vredenburgh JJ, Rich JN, Reardon DA, Desjardins A, Friedman HS. In reply. Journal of Clinical Oncology. 2008 Nov 10;26(32):5305.
Vredenburgh, J. J., et al. “In reply.” Journal of Clinical Oncology, vol. 26, no. 32, Nov. 2008, p. 5305. Scopus, doi:10.1200/JCO.2008.18.0372.
Vredenburgh JJ, Rich JN, Reardon DA, Desjardins A, Friedman HS. In reply. Journal of Clinical Oncology. 2008 Nov 10;26(32):5305.
Published In
Journal of Clinical Oncology
DOI
ISSN
0732-183X
Publication Date
November 10, 2008
Volume
26
Issue
32
Start / End Page
5305
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences